Portfolio of Biotech Stocks: Diabetes

Here is a sample of 4 biotech stocks that provide diabetes treatments.

4 Biotech Stocks: Diabetes

Stock & Price Chart


Recent Prices &
Annualized Return

MannKind Corp.MNKD
Insulet CorporationPODD
Price data from Quandl as of most recent close.

To inspect the performance of the Biotech Stocks: Diabetes portfolio, see the chart of portfolio below. Portfolio values are computed using monthly closes for stocks from Quandl.

All 4 stocks are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each stock at its closing monthly price for the current date in 2009. All prices are adjusted for splits and dividends.

The current value of a $10,000 investment is $52,331. The percent return is 423.31%. The annualized return is 21.04%.

NOTE: The stocks included in the table and chart are representative of the industry. They are not recommendations.

Related Portfolios

Portfolio of Biotech Stocks

Portfolio of Dividend-Paying Pharmaceutical Stocks